Company profilePharmaceutical#1046 of 1,318 in Pakistan✓ No DRAP alerts

Getz Pharma (Pvt) Limited DSL: DSL 0655

Pharmaceutical company · 3 brands · 7 molecules

Ranked #43 of 44 companies in Antineoplastics

3 registered products 7 pharmaceutical brands 7 distinct molecules 0 DRAP alerts

Company overview

3
registered products
7
pharmaceutical brands
7
distinct molecules
1
therapeutic classes
0
DRAP alerts

Getz Pharma (Pvt) Limited DSL: DSL 0655 is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 3 product registrations across 7 distinct molecules. Its portfolio is concentrated in Antineoplastics. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by Getz

1 product matched in our catalogue — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

1
ceilings with an approval date
0
not revised in 2+ years
2026
oldest approval year
20261

Top molecules by brand count

Salbutamol ...... 100 Mcg1 brand
Capecitabine ...... 500 Mg1 brand
Trastuzumab ...... 150 Mg1 brand
Trastuzumab ...... 440 Mg1 brand

Therapeutic classes

Antineoplastics · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official4 products · Rs 413.06 – Rs 174,457.91
Median across source: Rs 45,429.86

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

PharmEvo Private Limited4 shared molecules
AGP (PRIVATE) LTD.4 shared molecules
Roche Pakistan Limited.2 shared molecules
The Searle Company Limited2 shared molecules
Pharmasol (Pvt) Ltd.2 shared molecules

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

PharmEvo Private Limited holds 120 molecules not in this portfolio
AgomelatineAlcoholAmlodipineAnastrazoleApixabanAprepitant
AGP (PRIVATE) LTD. holds 143 molecules not in this portfolio
AmikacinAminophyllineAmlodipineAmoxicillinAprepitantArtemether
MACTER INTERNATIONAL (PVT) LTD. holds 178 molecules not in this portfolio
000 I.U10Ug Polysaccharides Covalently Bound To 20Ug To 32Ug Of Tetanus ToxoidAlbendazoleAlbuterolAlfacalcidolAluminium Hydroxide

Get the full profile for Getz

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.